WO2004050685A3 - Antifungal therapeutic agents - Google Patents

Antifungal therapeutic agents Download PDF

Info

Publication number
WO2004050685A3
WO2004050685A3 PCT/US2003/038595 US0338595W WO2004050685A3 WO 2004050685 A3 WO2004050685 A3 WO 2004050685A3 US 0338595 W US0338595 W US 0338595W WO 2004050685 A3 WO2004050685 A3 WO 2004050685A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutic agents
antifungal therapeutic
antifungal
compositions
animals
Prior art date
Application number
PCT/US2003/038595
Other languages
French (fr)
Other versions
WO2004050685A2 (en
Inventor
Jorge Sanchez-Quesada
Edelmira Cabezas
Original Assignee
Adaptive Therapeutics Inc
Jorge Sanchez-Quesada
Weinberger Dana
Edelmira Cabezas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adaptive Therapeutics Inc, Jorge Sanchez-Quesada, Weinberger Dana, Edelmira Cabezas filed Critical Adaptive Therapeutics Inc
Priority to AU2003297657A priority Critical patent/AU2003297657A1/en
Publication of WO2004050685A2 publication Critical patent/WO2004050685A2/en
Publication of WO2004050685A3 publication Critical patent/WO2004050685A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The present invention provides novel antifungal agents and compositions that include cyclic peptides having an amino acid sequence of between four and about ten alternating D- and L-α-amino acids. Pharmaceutical compositions having antifungal activity and methods of treating fungal infections in animals are also provided.
PCT/US2003/038595 2002-11-29 2003-11-26 Antifungal therapeutic agents WO2004050685A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003297657A AU2003297657A1 (en) 2002-11-29 2003-11-26 Antifungal therapeutic agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42992302P 2002-11-29 2002-11-29
US60/429,923 2002-11-29

Publications (2)

Publication Number Publication Date
WO2004050685A2 WO2004050685A2 (en) 2004-06-17
WO2004050685A3 true WO2004050685A3 (en) 2004-12-16

Family

ID=32469390

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/038595 WO2004050685A2 (en) 2002-11-29 2003-11-26 Antifungal therapeutic agents

Country Status (2)

Country Link
AU (1) AU2003297657A1 (en)
WO (1) WO2004050685A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2463308C2 (en) * 2005-12-22 2012-10-10 НоваБиотикс Лимитед Cyclic antimicrobial peptides
US9181303B2 (en) * 2005-12-22 2015-11-10 Novabiotics Limited Treatment of bacterial infections with cyclic antimicrobial peptides
AU2012203804B2 (en) * 2005-12-22 2014-10-16 Novabiotics Limited Cyclic antimicrobial peptides
GB0702020D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
CN106852146B (en) 2014-05-21 2021-08-13 恩特拉达治疗学股份有限公司 Cell penetrating peptides and methods of making and using the same
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
EP3185880B1 (en) 2014-08-27 2020-02-12 Ohio State Innovation Foundation Improved peptidyl calcineurin inhibitors
US11576946B2 (en) 2018-01-29 2023-02-14 Ohio State Innovation Foundation Peptidyl inhibitors of calcineurin-NFAT interaction
TW201945014A (en) 2018-02-22 2019-12-01 美商安卓達治療股份有限公司 Compositions and methods for treating Mitochondrial Neurogastrointestinal Encephalopathy

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BARSUKOV ET AL: "2D H-NMR Study of confromational Flexibility of L, D-Peptides Gramiciin A and its analgos", PEPTIDES, PROC. EUR. PEPT. SYMP., 20TH, 1988, pages 471 - 473, XP002903620 *
REZA GHADIRI M. ET AL: "Self-Assembling Organic Nanotubes Based On A Cyclic Peptide Architecture", NATURE, vol. 366, November 1993 (1993-11-01), pages 324 - 327, XP002936460 *
SANCHEZ-QUESEDA J. ET AL: "Cyclic Peptides as Molecular Adapters for a Pore-Forming Protein", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 122, no. 48, December 2000 (2000-12-01), pages 11757 - 11766, XP002903604 *

Also Published As

Publication number Publication date
AU2003297657A1 (en) 2004-06-23
AU2003297657A8 (en) 2004-06-23
WO2004050685A2 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
WO2007046103A3 (en) System for iontophoretic transdermal delivery of polymeric agents and methods of use thereof
WO2000055125A3 (en) N-cyanomethyl amides as protease inhibitors
DE60331049D1 (en) CONJUGATES OF CYTOTOXIC AGENTS AND BIOLOGICALLY ACTIVE PEPTIDES
WO2004078777A3 (en) Dipeptidyl-peptidase protected proteins
WO2002090503A3 (en) Anti-microbial peptides and compositions
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
DE60239707D1 (en) ANTIMICROBIAL CATIONIC PEPTIDES AND FORMULATIONS CONTAINING THEM
ATE366317T1 (en) PRODUCTION OF PEPTIDES AND PROTEINS BY ACCUMULATION IN PROTEIN BODY DERIVED FROM THE ENDOPLASMATIC RETICULUM
WO2007021886A3 (en) Truncated memapsin 2 for use for treating alzheimer's disease
WO2004091497A3 (en) Methods and compositions for increasing the anaerobic working capacity in tissues
WO2004074486A3 (en) Fusion proteins of interferon alpha muteins with improved properties
WO2004050685A3 (en) Antifungal therapeutic agents
DE602004014145D1 (en) FROM RASGAP-DERIVED PEPTIDE TO THE TARGETED CANCER OF THE CANCER
WO2005023857A3 (en) Agent derived from tortoise spleen stimulating mammalian hemopoiesis
WO2005034889A3 (en) Method for imparting artificial tan to human skin
ATE326981T1 (en) ISOLATED PEPTIDES THAT MATCH AMINO ACID SEQUENCES OF NY-ESO-1 AND BIND TO MHC CLASS I AND MHC CLASS II MOLECULES, AND USES THEREOF
WO2005059131A3 (en) Protein binding miniature proteins and uses thereof
BR0312889A (en) Pegged t20 polypeptide
HUP0401732A2 (en) Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent
EP2431029A3 (en) Method of inhibiting prostate cancer cell proliferation
WO2004113386A3 (en) Modified hirudin proteins and t-cell epitopes in hirudin
DE60229883D1 (en) BIOLOGICALLY ACTIVE PEPTIDES
WO2000078803A3 (en) Use of eif4e binding agents in therapy
ATE441713T1 (en) TUMOR ANTIGEN PROTEIN AND USE THEREOF
AU2003208197A8 (en) Use of soluble fgl2 as an immunosuppressant

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP